Part 6/11:
Foreign firms recognize these shifts. For example, Merc, a prominent science and technology company, increased its investment in a research center in Shanghai by €14 million in 2024. They emphasize that China has become a priority market for new developments and that Chinese biotech innovations could benefit patients worldwide through partnerships, licensing, and co-development efforts.